recombinant human amh rhamh (R&D Systems)
Structured Review

Recombinant Human Amh Rhamh, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/Recombinant+Human+MIS%2FAMH+Protein%2C+CF/pm39258229-65-0-7
Average 93 stars, based on 15 article reviews
Images
1) Product Images from "Effect of AMH on primordial follicle populations in mouse ovaries and human pre-pubertal ovarian xenografts during doxorubicin treatment."
Article Title: Effect of AMH on primordial follicle populations in mouse ovaries and human pre-pubertal ovarian xenografts during doxorubicin treatment.
Journal: Frontiers in cell and developmental biology
doi: 10.3389/fcell.2024.1449156
Figure Legend Snippet: FIGURE 2 Treatment regimen for administration of anti-Müllerian hormone (AMH) and/or doxorubicin (DXR) to SCID mice (severe combined immunodeficient) containing human ovarian transplants. Ten days after human ovarian tissue was xenotransplanted into SCID mice, animals were intraperitoneally (IP) injected daily with PBS or rhAMH for 8 days with an additional single IP injection of PBS or DXR on the second day.
Techniques Used: Injection
Figure Legend Snippet: FIGURE 3 Analysis of mouse ovarian follicles in cultured pre-pubertal ovaries treated with DXR and AMH stained with H and E. (A) Representative images of morphologically healthy follicles (scale bar = 25 μm): i: Primordial follicles. ii-iv: Growing follicles (ii: Transitional; iii: Primary; iv: Secondary). (B) Unhealthy follicles (scale bar = 100 μm): black arrows denote pyknotic granulosa cells, red arrows denote atretic oocytes. (C) Total number of morphologically healthy primordial follicles in mouse ovaries treated with different concentrations of DXR. Values are presented as Mean ± S.E.M. Control n = 3; 50 ng/mL DXR n = 3; 100 ng/mL DXR n = 5; 200 ng/mL DXR n = 3. (D) Number of morphologically healthy primordial follicles in mouse ovaries cultured with different concentrations of rhAMH and with or without exposure to DXR. Values represent Mean ± S.E.M ns = not significant, *P < 0.05, ***P < 0.001, ****P < 0.0001.
Techniques Used: Cell Culture, Staining, Control
Related Articles
Recombinant:Article Title: Anti-Müllerian hormone inhibits proliferation and induces apoptosis in epithelial ovarian cancer cells by regulating the cell cycle and decreasing the secretion of stem cell factor Article Snippet: Human EOC cell lines (OVCAR3 and OVCAR8) purchased from the Institute of Biochemistry and Cell Biology at the Chinese Academy of Sciences (Shanghai, China) were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (Invitrogen; Thermo Fisher Scientific, Inc.). .. Article Title: Gene therapy with feline anti-Müllerian hormone analogs disrupts folliculogenesis and induces pregnancy loss in female domestic cats Article Snippet: The secondary antibody (diluted 1:10,000) was Amersham ECL sheep-derived horseradish peroxidase-conjugated anti-mouse IgG (Cytiva, Mount Waverly, VIC, Australia; catalog # NA931-1ML), with detection of immunoreactive proteins using Lumi-light chemiluminescence reagents (Roche, Basel, Switzerland) and a ChemiDoc TM MP system (Bio-Rad, Hercules, CA, United States) with Image Lab TM software (version 4.1; Bio-Rad). .. Article Title: Xenotransplantation of pre-pubertal ovarian cortex and prevention of follicle depletion with anti-Müllerian hormone (AMH). Article Snippet: .. The osmotic pump (ALZET Osmotic Pumps, model 1002, Cupertino, CA, USA) administered either normal saline (placebo group) or Article Title: Effect of AMH on primordial follicle populations in mouse ovaries and human pre-pubertal ovarian xenografts during doxorubicin treatment. Article Snippet: .. Article Title: Anti-Mullerian hormone (AMH) protects ovarian follicle loss by downregulating granulosa cell function in in vitro and in vivo models. Article Snippet: Purpose AMH inhibits hormone production in luteinized granulosa cells (GCs) and stalls ovarian follicle development in vitro and in vivo.. We sought to confirm AMH’s mechanism of action through SMAD activation and investigate AMH inhibition of follicle development and function, in vitro and in vivo.. Methods A primary culture of GCs isolated from follicular fluid was used, and cells were treated with recombinant AMH (rAMH) or placebo for 24 h. For the mouse model, 18-weeks old C57BL female mice were either euthanized at the beginning or treated with rAMH or normal saline for 3 weeks. Article Title: Gene therapy with feline anti-Müllerian hormone analogs disrupts folliculogenesis and induces pregnancy loss in female domestic cats. Article Snippet: The secondary antibody (diluted 1:10,000) was Amersham ECL sheep-derived horseradish peroxidase-conjugated anti-mouse IgG (Cytiva, Mount Waverly, VIC, Australia; catalog # NA931-1ML), with detection of immunoreactive proteins using Lumi-light chemiluminescence reagents (Roche, Basel, Switzerland) and a ChemiDocTM MP system (Bio-Rad, Hercules, CA, United States) with Image LabTM software (version 4.1; Bio-Rad). .. Article Title: Single-cell sequencing reveals suppressive transcriptional programs regulated by MIS/AMH in neonatal ovaries Article Snippet: Postnatal day 2 (PND2) mouse or/and rat full ovaries were harvested and placed on trans-well permeable supports (Costar) and were cultured (37C, 5% CO2) for 48 hours in DMEM-F12 media supplemented with 0.1% Albumax (Thermo Fisher Scientific), penicillin-streptomycin (Invitrogen), 0.1% FBS (Thermo Fisher Scientific), 27.5 μg/ml transferrin (Sigma-Aldrich, Saint-Louis, MO), and 0.05 mg/ml L- ascorbic acid (SigmaAldrich) (3),(4). .. The ovaries were treated either with mock MIS, Positive Control:Article Title: Gene therapy with feline anti-Müllerian hormone analogs disrupts folliculogenesis and induces pregnancy loss in female domestic cats Article Snippet: The secondary antibody (diluted 1:10,000) was Amersham ECL sheep-derived horseradish peroxidase-conjugated anti-mouse IgG (Cytiva, Mount Waverly, VIC, Australia; catalog # NA931-1ML), with detection of immunoreactive proteins using Lumi-light chemiluminescence reagents (Roche, Basel, Switzerland) and a ChemiDoc TM MP system (Bio-Rad, Hercules, CA, United States) with Image Lab TM software (version 4.1; Bio-Rad). .. Article Title: Gene therapy with feline anti-Müllerian hormone analogs disrupts folliculogenesis and induces pregnancy loss in female domestic cats. Article Snippet: The secondary antibody (diluted 1:10,000) was Amersham ECL sheep-derived horseradish peroxidase-conjugated anti-mouse IgG (Cytiva, Mount Waverly, VIC, Australia; catalog # NA931-1ML), with detection of immunoreactive proteins using Lumi-light chemiluminescence reagents (Roche, Basel, Switzerland) and a ChemiDocTM MP system (Bio-Rad, Hercules, CA, United States) with Image LabTM software (version 4.1; Bio-Rad). .. Saline:Article Title: Xenotransplantation of pre-pubertal ovarian cortex and prevention of follicle depletion with anti-Müllerian hormone (AMH). Article Snippet: .. The osmotic pump (ALZET Osmotic Pumps, model 1002, Cupertino, CA, USA) administered either normal saline (placebo group) or Article Title: Anti-Mullerian hormone (AMH) protects ovarian follicle loss by downregulating granulosa cell function in in vitro and in vivo models. Article Snippet: Purpose AMH inhibits hormone production in luteinized granulosa cells (GCs) and stalls ovarian follicle development in vitro and in vivo.. We sought to confirm AMH’s mechanism of action through SMAD activation and investigate AMH inhibition of follicle development and function, in vitro and in vivo.. Methods A primary culture of GCs isolated from follicular fluid was used, and cells were treated with recombinant AMH (rAMH) or placebo for 24 h. For the mouse model, 18-weeks old C57BL female mice were either euthanized at the beginning or treated with rAMH or normal saline for 3 weeks. other:Article Title: Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro Article Snippet: Ovarian tissue was transported to the laboratory in dissection medium (Leibovitz medium (Invitrogen Ltd, Paisley, UK) supplemented with sodium pyruvate (2 mM), L-glutamine (2 mM) (both Invitrogen Ltd), human serum albumin (HSA) (3 mg/ml), penicillin G (75 μg/ml), and streptomycin (50 μg/ml) (Sigma Chemicals, Poole, Dorset, UK)). Incubation:Article Title: Anti-Mullerian hormone (AMH) protects ovarian follicle loss by downregulating granulosa cell function in in vitro and in vivo models. Article Snippet: Purpose AMH inhibits hormone production in luteinized granulosa cells (GCs) and stalls ovarian follicle development in vitro and in vivo.. We sought to confirm AMH’s mechanism of action through SMAD activation and investigate AMH inhibition of follicle development and function, in vitro and in vivo.. Methods A primary culture of GCs isolated from follicular fluid was used, and cells were treated with recombinant AMH (rAMH) or placebo for 24 h. For the mouse model, 18-weeks old C57BL female mice were either euthanized at the beginning or treated with rAMH or normal saline for 3 weeks. Control:Article Title: Anti-Mullerian hormone (AMH) protects ovarian follicle loss by downregulating granulosa cell function in in vitro and in vivo models. Article Snippet: Purpose AMH inhibits hormone production in luteinized granulosa cells (GCs) and stalls ovarian follicle development in vitro and in vivo.. We sought to confirm AMH’s mechanism of action through SMAD activation and investigate AMH inhibition of follicle development and function, in vitro and in vivo.. Methods A primary culture of GCs isolated from follicular fluid was used, and cells were treated with recombinant AMH (rAMH) or placebo for 24 h. For the mouse model, 18-weeks old C57BL female mice were either euthanized at the beginning or treated with rAMH or normal saline for 3 weeks. Clinical Proteomics:Article Title: Anti-Mullerian hormone (AMH) protects ovarian follicle loss by downregulating granulosa cell function in in vitro and in vivo models. Article Snippet: Purpose AMH inhibits hormone production in luteinized granulosa cells (GCs) and stalls ovarian follicle development in vitro and in vivo.. We sought to confirm AMH’s mechanism of action through SMAD activation and investigate AMH inhibition of follicle development and function, in vitro and in vivo.. Methods A primary culture of GCs isolated from follicular fluid was used, and cells were treated with recombinant AMH (rAMH) or placebo for 24 h. For the mouse model, 18-weeks old C57BL female mice were either euthanized at the beginning or treated with rAMH or normal saline for 3 weeks. Concentration Assay:Article Title: Anti-Mullerian hormone (AMH) protects ovarian follicle loss by downregulating granulosa cell function in in vitro and in vivo models. Article Snippet: Purpose AMH inhibits hormone production in luteinized granulosa cells (GCs) and stalls ovarian follicle development in vitro and in vivo.. We sought to confirm AMH’s mechanism of action through SMAD activation and investigate AMH inhibition of follicle development and function, in vitro and in vivo.. Methods A primary culture of GCs isolated from follicular fluid was used, and cells were treated with recombinant AMH (rAMH) or placebo for 24 h. For the mouse model, 18-weeks old C57BL female mice were either euthanized at the beginning or treated with rAMH or normal saline for 3 weeks. |
![Reaction schemes <t>and</t> <t>LC-MS</t> analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3502/pmc13123502/pmc13123502__gr2.jpg)
